Listed

Nutex Health Inc.: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Nov 19, 2019 and accepted by EDGAR at Nov 19, 2019, 11:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-07-01 to 2019-09-30$7.5kus-gaap:Revenues
Revenue9 months2019-01-01 to 2019-09-30$19.2kus-gaap:Revenues
Cost of revenue3 months2019-07-01 to 2019-09-30$10.0kus-gaap:CostOfRevenue
Cost of revenue9 months2019-01-01 to 2019-09-30$26.3kus-gaap:CostOfRevenue
Gross profit3 months2019-07-01 to 2019-09-30−$2.5kus-gaap:GrossProfit
Gross profit9 months2019-01-01 to 2019-09-30−$7.2kus-gaap:GrossProfit
Operating income3 months2019-07-01 to 2019-09-30−$363.8kus-gaap:OperatingIncomeLoss
Operating income9 months2019-01-01 to 2019-09-30−$1.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-07-01 to 2019-09-30$10.0kus-gaap:InterestExpense
Interest expense9 months2019-01-01 to 2019-09-30$234.3kus-gaap:InterestExpense
Net income3 months2019-07-01 to 2019-09-30−$373.7kus-gaap:NetIncomeLoss
Net income9 months2019-01-01 to 2019-09-30−$1.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-30−$0.48us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2019-01-01 to 2019-09-30−$2.13us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2019-01-01 to 2019-09-30−$332.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-09-30$10.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-30$53.0kus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$2.1mus-gaap:Assets
Total liabilitiesAt period end2019-09-30$1.5mus-gaap:Liabilities
Shareholders' equityAt period end2019-09-30$639.9kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001607062-19-000457. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.